Articles from Afya Limited

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three-month period ended March 31, 2025 (first quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, in addition to the Press Release released by the company on December 19th, 2024, announced today the closing of its acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Faculdade Masterclass Ltda. (“FACULDADE ÚNICA DE CONTAGEM” or “FUNIC”), located in Contagem, a city in the metropolitan area of Belo Horizonte, the capital of the State of Minas Gerais.

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the fourth quarter and full-year period ended December 31, 2024. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), Brazil’s leading medical education group and provider of medical practice solutions, announced that its board of directors (the “Board”) approved its first distribution of a cash dividend.

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that it has entered into a share purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Faculdade Masterclass Ltda. (“Faculdade Única de Contagem” or “FUNIC”), present in Contagem (MG).

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three and nine-month periods ended September 30, 2024 (third quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that it will report third-quarter and nine months 2024 financial results for the period ended September 30th, 2024, following the close of the market on Wednesday, November 13th, 2024 and will host a corresponding conference call and webcast at 05:00 pm EST.

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that it will host its Afya Day on October 29th, 2024. The event will be held in a hybrid format, combining both in-person and online participation, and will feature presentations from Afya’s executive team, covering the Company's growth, business strategy and future outlook.

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced a public commitment to achieve 5 million free health consultations by 2030, in line with Sustainable Development Goal 3 (SDG 3), which aims to ensure healthy lives and promote well-being for all people, at all ages.

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that following the conclusion of an administrative procedure, the Ministry of Education (“MEC”), has granted the request for reconsideration submitted by Universidade do Grande Rio Professor José de Souza Herdy (“Unigranrio”).

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil announced today that its wholly-owned subsidiary, Afya Participações S.A., has received the total disbursement of BRL500.0 million under the loan agreement with International Finance Corporation ("IFC") to support the Company’s expansion program.

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three and six-month period, which ended on June 30, 2024 (second quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil announced today that its wholly-owned subsidiary, Afya Participações S.A., entered into a loan agreement with International Finance Corporation ("IFC") to finance its expansion program, through acquisitions.

Afya Limited (Nasdaq: AFYA; B3: A2FY34), the leading medical education group and medical practice solutions provider in Brazil, announces the release of its 2023 Sustainability Report.

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the increase of 80 medical seats of Centro Universitário de Maceió (UNIMA Alagoas), in the city of Maceió, located in the state of Alagoas, which will result in an additional payment of R$ 1.25 million per increased seat approval updated by IPCA since 2nd January 2023 until the payment date.

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, in addition to the Press Release released by the Company on May 2nd, 2024, announced today the closing of its acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Unidom Participações S.A. (“Unidompedro” and “Faculdade Dom Luiz”), present in Salvador (BA), Luis Eduardo Magalhães (BA), Barreiras (BA) and Ribeira do Pombal (BA).

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that Mrs. Shobhna Mohn notified the Company of her intent to resign as a member of the Board of Directors of the Company, effective as of June 30, 2024, as she also steps down from her operational role at Bertelsmann, one of the key shareholders of Afya. Mrs. Mohn's decision is unrelated to any matter associated with the Company, its operations, policies, or practices.

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that the resolution set out in its Notice of Annual General Meeting dated May 17, 2024 was duly passed at its Annual General Meeting held today: the approval and ratification of Afya’s financial statements and the auditor’s report for the fiscal year ended December 31, 2023.

Notice is hereby given that an Annual General Meeting of the Company (the "AGM") will be held at the offices of Afya Participações S.A. (Nasdaq: AFYA; B3: A2FY34) (the "Company"), Alameda Oscar Niemeyer, No. 119, 15th Floor, Vila da Serra, Nova Lima, Minas Gerais, Brazil, Zip Code: 34.006-056, and virtually by accessing the following link https://web.lumiconnect.com/283874046 (password: afya2024), on the 5th day of June 2024 at 10:00 a.m. BRT, for the purpose of considering and, if thought fit, passing and approving the following resolution:

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2024 (first quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, announced today that it has entered into a share purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Unidom Participações S.A. (“Unidompedro” and “Faculdade Dom Luiz”), present in Salvador (BA), Luis Eduardo Magalhães (BA), Barreiras (BA) and Ribeira do Pombal (BA).

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the fourth quarter and full-year period ended December 31, 2023. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the increase of 40 medical seats of Faculdades Integradas Padrão (FIP Guanambi), in the city of Guanambi, located in the state of Bahia, which will result in an additional payment of R$49,6 million.

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three and nine-month period ended September 30, 2023. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, today announced an additional acquisition, through its wholly-owned subsidiary Afya Participações S.A. (“Afya Brazil”), of an additional 15% of Centro de Ciências em Saúde de Itajubá S.A. ("CCSI”;”FMIT”), consolidating our position of ownership to 75% of the total share capital.

Afya Limited, or “Afya” (Nasdaq: AFYA, B3: A2FY34) announced today that will report third-quarter and nine months 2023 financial results for the period ended September 30th, 2023, following the close of the market on Monday, November 13th, 2023 and will host a corresponding conference call and webcast at 05:00 pm EST.

Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three and six-month period ended June 30, 2023. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that it will report second-quarter and first half 2023 financial results for the period ended June 30, 2023, following the close of the market on Monday, August 28, 2023 and will host a corresponding conference call and webcast at 05:00 pm EDT.

Afya Limited, or “Afya” (Nasdaq: AFYA, B3:A2FY), announced today the start of negotiation of its non-sponsored Brazilian Depositary Receipts (BDRs), with a 1-for-2 stock split, aimed to provide investment opportunities on Afya for Brazilian investors.

Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will host its Investor and ESG Day on Thursday, July 6th, 2023, at 9:00 am EST. Attendees will hear from Afya’s business executives the Company's evolution, business strategy, ESG initiatives, present and future perspectives.

Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that the resolutions set out in its Notice of Annual General Meeting dated May 8, 2023 were duly passed at its Annual General Meeting held today: (1) the approval and ratification of Afya’s financial statements as of and for the fiscal year ended December 31, 2022; (2) the approval of João Paulo Seibel de Faria as a director of the Company with immediate effect to hold office for a two year term; (3) the approval of Vanessa Claro Lopes as a director of the Company with immediate effect to hold office for a two year term; (4) the approval of Miguel Filisbino Pereira de Paula as a director of the Company with immediate effect to hold office for a two year term; and (5) the approval of Marcelo Ken Suhara as a director of the Company with immediate effect to hold office for a two year term.

Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2023 (first quarter 2023). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited, or Afya (Nasdaq: AFYA), today announced that, after the completion of its third share repurchase program, which resulted in the purchase of 1,874,457 Class A common shares, its Board of Directors has approved a new share repurchase program providing for the repurchase of up to 2,000,000 of its outstanding Class A common shares (the “Shares”), which represents approximately 5.8% of its free float in accordance with the conditions established by the Board of Directors on March 23, 2023. Accordingly, in connection with repurchases under the new program, Afya today announced that will enter into a written trading plan (the “Plan”) with BofA Securities, Inc., as the independent broker-dealer, which is intended to comply with the requirements of Rule 10b5-1 (“Rule 10b5-1”) and Rule 10b-18 (“Rule 10b-18”), each under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”).

Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the fourth quarter and full-year period ended December 31, 2022. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited, or Afya (Nasdaq: AFYA), in addition to the Press Release released by the Company on October 13, 2022, today announced the closing of its acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Sociedade Educacional e Cultural Sergipe DelRey Ltda. (“DelRey”), that encompasses the operations of Centro Universitário Tiradentes Alagoas (“UNIT Alagoas”) and Faculdade Tiradentes Jaboatão dos Guararapes (“FITS Jaboatão dos Guararapes”). The transaction does not enclose the “UNIT” and “FITS” brands, which will be licensed for Afya during the first year of operation.

Afya Limited or Afya (Nasdaq: AFYA) today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the increase of 64 medical seats of Faculdade Santo Agostinho, in the city of Itabuna, located in the state of Bahia.

Afya Limited, or Afya (Nasdaq: AFYA) today announced the closing of the issuance, through its wholly-owned subsidiary Afya Participações S.A., of 500,000 simple, non-convertible, unsecured debentures in a single series, each with a par value of R$1,000, totaling an aggregate amount of R$500 million (“Debentures”), by means of a public distribution with restricted placement efforts in the Brazilian market (the “Offering”), under the terms of the Brazilian Securities and Exchange Commission (“CVM”) Rule No. 476, dated January 16, 2009, and was not generally made anywhere outside of Brazil, including in the United States or to US investors. Accordingly, the Debentures were not and will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act.

Afya Limited, or Afya (Nasdaq: AFYA), today announced that Mr. Flávio Dias, a board member since July 2020, has ended his term as an independent member of the Board of Directors, and will not be renewed. The remaining independent board members will have their term extended until Afya’s next Annual General Meeting. Furthermore, Afya also announced that Mr. Daulins Emilio, a board member since August 2019, has submitted his resignation letter as a member of the Board of Directors and, consequently, Bertelsmann SE&Co. KGaA has appointed Mrs. Tina Krebs as his replacement, effective as of today. With these changes, the number of women members now represents 40% of the Board of Directors.

Afya Limited, or Afya (Nasdaq: AFYA), today announced its intention to issue, through its wholly-owned subsidiary Afya Participações S.A., 500,000 simple, non-convertible, unsecured debentures in a single series, each with a par value of R$1,000, totaling an aggregate amount of R$500 million (“Debentures”), by means of a proposed public distribution with restricted placement efforts in the Brazilian market (the “Offering”), under the terms of the Brazilian Securities and Exchange Commission (“CVM”) Rule No. 476, dated January 16, 2009, and is not being generally made anywhere outside of Brazil, including in the United States or to US investors. Accordingly, the Debentures will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act.

Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three and nine-month period ended September 30, 2022 (third quarter 2022). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report Third Quarter and Nine Months 2022 Financial Results for the period ended September 30, 2022, following the close of the market on Monday, November 21st, 2022 and will host a corresponding conference call and webcast at 05:00 pm ET.

Afya Limited, or Afya (Nasdaq: AFYA), announced today that it has entered into a share purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Sociedade Educacional e Cultural Sergipe DelRey Ltda. (“DelRey”), that encompasses the operations of Centro Universitário Tiradentes Alagoas (“UNIT Alagoas”) and Faculdade Tiradentes Jaboatão dos Guararapes (“FITS Jaboatão dos Guararapes”). The transaction does not enclose the “UNIT” and “FITS” brands, which will be licensed for Afya during the first year of operation.

Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three and six-month period ended June 30, 2022 (second quarter 2022). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report Second-Quarter and First Half 2022 Financial Results for the period ended June 30, 2022, following the close of the market on Monday, August 22nd, 2022 and will host a corresponding conference call and webcast at 05:00 pm ET.

Afya Limited or Afya (Nasdaq: AFYA) announces that it has released its 2021 Sustainability Report. The report highlights the Company’s commitment and progress on environmental, social, and governance (ESG) initiatives.

Afya Limited, or Afya (Nasdaq: AFYA) today announced the acquisition, through its wholly-owned subsidiary Afya Participações S.A, of 100% of Glic.

Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2022 (first quarter 2022). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited, or Afya (Nasdaq: AFYA), further to the press releases issued by the Company on March 7, 2022 and April 25, 2022, today announced the closing of the transaction where Bertelsmann SE& Co. KGaA, or “Bertelsmann” acquired 6,000,000 Class B common shares of Afya at the purchase price of US$26.90 per share, from Nicolau Carvalho Esteves, Rosângela de Oliveira Tavares Esteves and NRE Capital Ventures Ltd (together with Nicolau Carvalho Esteves and Rosângela de Oliveira Tavares Esteves, the “Esteves Family”). As a result of the closing of the transaction, Bertelsmann and the Esteves family will beneficially own ~57.5% and ~33.0% voting interest, and ~31.0% and ~18.0% of the total shares, respectively, in Afya.

Afya Limited, or “Afya” (Nasdaq: AFYA) announced today that the resolutions set out in its Notice of Annual General Meeting dated April 12, 2022 were duly passed at its Annual General Meeting held today: (1) the approval and ratification of Afya’s financial statements as of and for the fiscal year ended December 31, 2021; and (2) the approval of the Amended and Restated Memorandum and Articles of Association available at Afya’s website at https://ir.afya.com.br, subject to and with effect from Closing of the transaction disclosed in the Form 13D/A on March 4, 2022, between Esteves Family and Bertelsmann SE & Co. KGaA, accessible at the Company’s website at https://ir.afya.com.br.

Afya Limited, or Afya (Nasdaq: AFYA), today announced that it was notified that an affiliate of Bertelsmann SE& Co. KGaA, or “Bertelsmann” has agreed to buy 6,000,000 Class B common shares of Afya at the purchase price of US$26.90 per share, pursuant to a binding offer made by Nicolau Carvalho Esteves, Rosângela de Oliveira Tavares Esteves and NRE Capital Ventures Ltd (together with Nicolau Carvalho Esteves and Rosângela de Oliveira Tavares Esteves, the “Esteves Family”), as previously disclosed to the market on March 7, 2022. Following the transaction, Bertelsmann and the Esteves Family will beneficially own 57.5% and 33.1% voting interest, and 31.0% and 17.8% of the total shares respectively, in Afya. The transaction is subject to customary closing conditions and is expected to close on May 4, 2022.

Afya Limited, or Afya (Nasdaq: AFYA), announced that Mr. Paulo Passoni, a board member since May 2021, has submitted his resignation letter as a member of the Board of Directors. Mrs. Maria Tereza Azevedo was appointed as his replacement effective as of today.

Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report first-quarter 2022 financial results for the period ended March 31, 2022, following the close of the market on Monday, May 23rd, 2022 and will host a corresponding conference call and webcast at 05:00 pm EDT.

Afya Limited, or Afya (Nasdaq: AFYA) Notice is hereby given that an Annual General Meeting of the Company (the "AGM") will be held at the offices of Afya Participações S.A., Alameda Oscar Niemeyer, No. 119, Room 504, Vila da Serra, Nova Lima, Minas Gerais, Brazil, Zip Code: 34.006-056, and virtually by accessing the following link (https://web.lumiagm.com/283874046; password: afya2022), on the 29th day of April, 2022 at 11:00 am, Brasília time for the purpose of considering and, if thought fit, passing and approving the following resolutions:

Afya Limited, or Afya (Nasdaq: AFYA) today announced the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of CardioPapers.

Afya Limited (NASDAQ: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health service provider in Brazil, reported today financial and operating results for the three and twelve-month period ended December 31, 2021 (fourth quarter 2021 and full year 2021, respectively). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited, or Afya (Nasdaq: AFYA) today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the operations of the medical schools in Bragança, in the State of Pará, and Manacapuru, in the State of Amazonas, both under Mais Médicos II program.

Afya Limited, or Afya (Nasdaq: AFYA) has executed the purchase agreement for the acquisition of 100% of the total share capital of Além da Medicina, through its wholly-owned subsidiary Afya Participações S.A. The consummation is subject to certain customary precedent conditions.

Afya Limited, or Afya (Nasdaq: AFYA) today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the operations of the medical schools in Abaetetuba, in the State of Pará, and Itacoatiara, in the State of Amazonas, both under Mais Médicos II program.

Afya Limited, or Afya (Nasdaq: AFYA), today announced that, after the completion of its second share repurchase program, that resulted in the purchase of 1,383,108 Class A common shares, its Board of Directors has approved a new share repurchase program. Under the share repurchase program, Afya may repurchase up to 1,874,457 of its outstanding Class A common shares which represents 4 % of its free float, in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning on January 27, 2022 until the earlier of the completion of the repurchase or December 31, 2022, depending upon market conditions.

Afya Limited, or Afya (Nasdaq: AFYA) today announced that it is one of 418 companies across 45 countries and regions to join the 2022 Bloomberg Gender-Equality Index (GEI), a modified market capitalization-weighted index that aims to track the performance of public companies committed to transparency in gender-data reporting. This reference index measures gender equality across five pillars: female leadership & talent pipeline, equal pay & gender pay parity, inclusive culture, anti-sexual harassment policies, and pro-women brand.

Afya Limited, or Afya (Nasdaq: AFYA), today announced that Júlio de Angeli, its Vice President of Innovation & Digital Services, notified the company of his intention to leave for personal reasons. Mr. de Angeli will remain in the company to ensure an effective transition of his duties until the end of January 2022. “We are grateful for the time Mr. de Angeli has spent with us developing our digital services strategy and we wish him all the best,” said Virgilio Gibbon, CEO of Afya.

Afya Limited (NASDAQ: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health service provider in Brazil, reported today financial and operating results for the three and nine-months period ended September 30, 2021 (third quarter 2021). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited, or Afya (Nasdaq: AFYA) today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the operation of the medical school in Garanhuns in the State of Pernambuco.

Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report third quarter 2021 financial results for the period ended September 30, 2021, following the close of the market on Monday, November 22, 2021.

Afya Limited, or Afya (Nasdaq: AFYA), today announced that, after the completion of its first share repurchase program on October 21, 2021 that resulted in the purchase of 1,015,844 Class A common shares, its Board of Directors has approved a new share repurchase program. Under the share repurchase program, Afya may repurchase up to 1,383,108 of its outstanding Class A common shares in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning on October 28, 2021 until the earlier of the completion of the repurchase or December 31, 2022, depending upon market conditions.

Afya Limited or Afya (Nasdaq: AFYA) announces that Sustainalytics, a leading ESG and corporate governance research firm, has rated Afya as a “low risk” ESG Risk Rating company and in the 10th percentile in the Sustainalytics database of over 13,500 organizations as of September, 2021. Afya is at low risk of experiencing material financial impacts from ESG factors, due to its low exposure and good policies and applied practices. For further information, please access: https://www.sustainalytics.com/.

Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group and digital health service provider in Brazil, reported today financial and operating results for the three and six-month period ended June 30, 2021 (second quarter 2021). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).

Afya Limited or Afya (Nasdaq: AFYA) announces that according to the United Nations Global Compact’s Sustainable Development Goals will assume a voluntary commitment to have at least 50% of women in its management positions by 2030.

Afya Limited, or Afya (Nasdaq: AFYA), hereby rectify the press release made on July 19, 2021 and announces that it will report second quarter 2021 financial results for the period ended June 30, 2021, following the close of the market on Thursday, August 26, 2021.